The Section of Neuroradiology at UCSF oversees analytic and research services for clinical trials assessing new therapies for diseases of the brain and spinal cord. These services include:

• Consultation on clinical trial design and implementation
• Quality assurance and centralized readings of MR and CT scans for multi institutional trials of new therapies designed to treat cerebral infarction (stoke), vasospasm, aneurysms, neoplasms of the brain, and demyelinating diseases such as multiple sclerosis.

Services include expert readings by senior neuroradiologists, qualitative and quantitative assessment of lesion volume and response over time, capabilities for high resolution film digitizing, volumetric analysis as well as magnetic resonance imaging and spectroscopy using state of the art, high resolution MR scanners at 1.5 and 3.0 Tesla.

We have served as the core lab for the Abbott Prourokinase trial, and the Sentis trial for the neuroflo cathter system by Coaxia, Inc.